50% off Premium Yearly

NASDAQ:TLRY
This summary was created by AI, based on 3 opinions in the last 12 months.
Tilray Inc. (TLRY-Q) has experienced mixed financial performance, with reported revenues showing a decline of 6.6% in the latest quarter, falling to $288M. This decline can raise concerns about demand and market challenges. Additionally, another revenue report indicates a more alarming drop of 32%, with gross profit diminishing sharply by 38.1%. The decline in both revenue and gross profit is notable as it may suggest underlying issues in production efficiency or sales strategies. However, despite these financial setbacks, the company has seen a notable spike in social media mentions, increasing by over 28% in the past 24 hours, pointing to potential market interest or engagement that could influence future performance. Investors should consider these dynamics and look closely at broader trends in the cannabis sector, particularly amidst discussions of potential rescheduling in the U.S., which might provide more favorable conditions for U.S.-based companies compared to their Canadian counterparts.
A lot of $$ was made, but now investors have come to realize marijuana is just a commodity. The company bears all the costs, but it has the federal/provincial government as a partner that shares equally in all the upside, but none of the down. Even advertising is restricted.
For a consumer stock, he holds Unilever.
So much wealth got destroyed in the cannabis sector, but Tilray will be one of the survivors. He can't offer a solid opinion about TLRY, because he needs to learn more about it, but he's starting to study the cannabis sector. Something will happen in the U.S. that will make banking for these companies allowable--and this will be a major move.
Tilray Inc. is a American stock, trading under the symbol TLRY (previously TLRY-Q on Stockchase) on the NASDAQ (TLRY). It is usually referred to as NASDAQ:TLRY or TLRY
In the last year, 3 stock analysts issued a Buy, Sell, or Hold rating on TLRY (previously TLRY-Q on Stockchase). 2 analysts recommended to BUY and 1 analyst recommended to SELL the stock. The latest stock analyst rating is . Read the latest stock experts' ratings for Tilray Inc..
Tilray Inc. was recommended as a Top Pick by Jim Cramer - Mad Money on 2022-09-30. Read the latest stock experts ratings for Tilray Inc..
Earnings reports or recent company news can cause the stock price to drop. Read stock experts' recommendations for Tilray Inc..
Tilray Inc. is followed by 90 investors on Stockchase and is a trending stock that is worth watching.
On 2026-06-17, Tilray Inc. (TLRY) stock closed at a price of $4.92.
Even with talk of rescheduling cannabis, US names offer significantly more upside than Canadian names. Look to the US if you want to take on this risk. If you own this one, use it as a tax loss.